HTR2A and Parkinson disease: For the first approach, we used membrane suspensions of human frontal cortex tissue of PD and control brains in order to perform receptor binding studies with the 5-HT2A-specific radioligand, [3H]-MDL 100907, and furthermore measured AS protein levels by western blotting.